All In Biotech

Investigational drug · Phase 3

PTP-01

Also called: MOTYS, allogeneic human placental tissue particulate

Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Knee Osteoarthritis.

Phase 3

Last checked: Nov 19, 2026Latest source record: Oct 16, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 3

Industry-sponsored trials

Phase 2 and 3 trials

1

1 still active

All registered trials

2

Any phase or sponsor naming "PTP-01"

First trial start

2025

Oct 14, 2025

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "PTP-01", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Knee Osteoarthritis

Approved drugs for the same conditions: Osteoarthritis

Largest trials

Live from ClinicalTrials.gov: studies naming "PTP-01" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 1 on PubMed

Also in development for Knee Osteoarthritis

  • EcnoglutideXW003, VRB-101Phase 38 trials

    Hangzhou Sciwind Biosciences Co., Ltd. · Obesity, Weight Management, OSA - Obstructive Sleep Apnea

  • hUC-MSCsmesenchymal stem cells, MSCPhase 38 trials

    Shenzhen Wingor Biotechnology Co., Ltd. · Knee Osteoarthritis, Crohn&Amp;#39;s, Crohn&Amp;#39;s Disease (CD)

  • JOINTSTEMPhase 32 trials

    R-Bio · Knee Osteoarthritis, Osteoarthritis, Knee

  • Reference DrugNSAIDsPhase 32 trials

    SANGMYUNG innovation · Retinal Vein Occlusion With Macular Edema, Knee Osteoarthritis

  • Medipost Co Ltd. · Knee Osteoarthritis, Bronchopulmonary Dysplasia, BPD

  • TTAX03Phase 22 trials

    BioTissue Holdings, Inc · Knee Osteoarthritis, Knee Pain Chronic, Knee Arthritis

  • NCR100Phase 21 trial

    Nuwacell Biotechnologies Co., Ltd. · Knee Osteoarthritis

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.